Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disease-related autoantibody profile in patients with systemic sclerosis

27 Jul 2017

Abstract excerpt

BACKGROUND: Autoantibodies (autoAbs) help in diagnosis and predicting clinical phenotypes in systemic sclerosis (SSc). AIM OF THE STUDY: To determine the clinical utility of 13 SSc-related autoAbs in SSc patients. MATERIAL AND METHODS: A total of 131 consecutive patients with SSc (111 female, mean age 58.1 ± 14 years; 49 with diffused cutaneous SSc [dcSSc] and 82 with limited cutaneous SSc [lcSSc]) were analysed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Systemic Lupus Erythematosus Research
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28749191
DOI: 10.1080/08916934.2017.1357699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease-related autoantibody profile in patients with systemic sclerosisPMID 28749191Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Comprehensive Autoantibody Profiles in Systemic Sclerosis: Clinical Cluster AnalysisSemantic proximity Read ↗

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisSemantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.Semantic proximity Read ↗

Extended Autoantibody Panel in Turkish Patients with Early-Stage Systemic Sclerosis: Co-expressions and Their Influences on Clinical PhenotypesSemantic proximity Read ↗

Evaluation of particle-based multi-analyte technology for autoantibody detection in systemic sclerosis: concordance with conventional methods and clinical associations.Semantic proximity Read ↗

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associationsSemantic proximity Read ↗

Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey.Semantic proximity Read ↗

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.Semantic proximity Read ↗

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.Semantic proximity Read ↗

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.